Martina Gogarty
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Journal: Molecular cancer
Published: January 31, 2025
Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Journal: Molecular cancer
Published: October 01, 2024
IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells.
Journal: Mucosal immunology
Published: April 07, 2021
Subcellular Localization of NR4A2 Orphan Nuclear Receptor Expression in Human and Mouse Synovial Joint Tissue.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 02, 2019
TNFα-dependent anhedonia and upregulation of hippocampal serotonin transporter activity in a mouse model of collagen-induced arthritis.
Journal: Neuropharmacology
Published: December 19, 2017
A comparison of three Peyer's patch "M-like" cell culture models: particle uptake, bacterial interaction, and epithelial histology.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: March 13, 2017
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.
Journal: Arthritis research & therapy
Published: September 09, 2016
Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.
Journal: Cancer research
Published: May 31, 2014
Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 08, 2013
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Journal: Molecular cancer
Published: August 06, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.
Journal: The American journal of pathology
Published: October 22, 2012
Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.
Journal: Arthritis and rheumatism
Published: June 08, 2012
Last Updated: 09/26/2026